Supply Chain Risk Management Standard to Address Pharma Compliance Concerns

A planned, first-of-its-kind, U.S. standard on supply chain risk management will include input from a handful of drugmakers to highlight the impact that compliance lapses have on supply chain security, says the chair of a newly formed industrywide panel developing the standard. The standard is intended to improve upon a recent compilation of best practices for managing supply chain risks, Marc Siegel, Commissioner for the ASIS International Global Standards Initiative and the panel’s chair, said. That compilation highlights natural disasters and man-made disruptions such as last year’s nuclear meltdown in Okuma, Japan. The new standard “has to talk about the different kinds of risk that supply chains around the world face, and compliance risks are a major one,” Siegel said.
Drug GMP Report